Optimizing Clozapine Benefit While Minimizing Adverse Effects with Concomitant Fluvoxamine Treatment in an Adolescent with Schizoaffective Disorder

Journal article

Peer reviewed

Timothy Rice, Stephanie Friedman, Jasmine Tatum, Naomi Weiss-Goldman, Yael Kufert and Barbara J Coffey

Journal of child and adolescent psychopharmacology, Vol.29(1), pp.66-71

2019-02-01

PMID: 30681385

Abstract

Advanced Pediatric Psychopharmacology

10 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.21 Psychiatry; 1.21.24 Schizophrenia
Web Of Science research areas: Pediatrics; Pharmacology & Pharmacy; Psychiatry
ESI research areas: Psychiatry/Psychology

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Optimizing Clozapine Benefit While Minimizing Adverse Effects with Concomitant Fluvoxamine Treatment in an Adolescent with Schizoaffective Disorder
Creators: Timothy Rice - 1Icahn School of Medicine at Mount Sinai, New York, New York
Stephanie Friedman - 1Icahn School of Medicine at Mount Sinai, New York, New York
Jasmine Tatum - 1Icahn School of Medicine at Mount Sinai, New York, New York
Naomi Weiss-Goldman - 1Icahn School of Medicine at Mount Sinai, New York, New York
Yael Kufert - 1Icahn School of Medicine at Mount Sinai, New York, New York
Barbara J Coffey - 2Department of Psychiatry and Behavioral Science, Miller School of Medicine, University of Miami, Miami, Florida
Publication Details: Journal of child and adolescent psychopharmacology, Vol.29(1), pp.66-71
Publisher: Mary Ann Liebert, Inc., publishers
Academic Unit: Miller School of Medicine; UMMG Dept of Psychiatry & Behavioral Sciences
Language: English
Resource Type: Journal article
PMID: 30681385
Record Identifier: 991031599088602976